Erregistroa posta elektronikoz bidali: ATPS-39 COMBINATORY EFFECT OF A NEWLY DESIGNED BIGUANIDE (HL156A) AND TEMOZOLOMIDE AGAINST GLIOBLASTOMA TUMORSPHERE